In a fresh setback for AstraZeneca a US health agency is questioning the efficacy of data on its Covid-19 vaccine from a large scale trial in the United States.
Source link
In a fresh setback for AstraZeneca a US health agency is questioning the efficacy of data on its Covid-19 vaccine from a large scale trial in the United States.
Source link
